Adenosine A1 receptor-dependent and -independent effects of the allosteric enhancer PD 81,723

Journal of Pharmacology and Experimental Therapeutics

Volumn 288, Issue 2, 1999, Pages 446-454

  Musser, Beth ^a   Mudumbi, Ramagopal V ^a,b   Liu, Jingwen ^a,b,d   Olson, Richard D ^a,b   Vestal, Robert E ^a,b,c,e  

^a Boise Veterans Affairs Medical Center   (United States)

^b St Luke's Mountain States Tumor Institute   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e Boise VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 4,5 DIMETHYL 3 (3 TRIFLUOROMETHYLBENZOYL)THIOPHENE; ADENOSINE A1 RECEPTOR; ADENOSINE RECEPTOR; ADENYLATE CYCLASE; ADENYLATE CYCLASE TOXIN; BORDETELLA VIRULENCE FACTOR; CHOLERA TOXIN; CYCLIC AMP; ENZYME INHIBITOR; FORSKOLIN; IMMUNOLOGICAL ADJUVANT; MAGNESIUM; PERTUSSIS TOXIN; THIOPHENE DERIVATIVE;

ANIMAL CELL; ARTICLE; BRAIN MEMBRANE; CHO CELL; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; ENZYME INHIBITION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; ANIMAL; BRAIN; DRUG ANTAGONISM; DRUG EFFECT; DRUG INTERACTION; DRUG POTENTIATION; ENZYME ACTIVATION; GENETIC TRANSFECTION; HAMSTER; KINETICS; MEMBRANE; METABOLISM; PHYSIOLOGY; RADIOASSAY; STIMULATION; ULTRASTRUCTURE;

ADENYLATE CYCLASE; ADENYLATE CYCLASE TOXIN; ADJUVANTS, IMMUNOLOGIC; ANIMALS; BRAIN; CHO CELLS; CHOLERA TOXIN; CRICETINAE; CYCLIC AMP; DRUG INTERACTIONS; ENZYME ACTIVATION; ENZYME INHIBITORS; FORSKOLIN; KINETICS; MAGNESIUM; MEMBRANES; PERTUSSIS TOXIN; RADIOLIGAND ASSAY; RATS; RECEPTORS, PURINERGIC P1; STIMULATION, CHEMICAL; THIOPHENES; TRANSFECTION; VIRULENCE FACTORS, BORDETELLA;

EID: 0032590063     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Amoah-Apraku B, Xu J, Lu JY, Pelleg A, Bruns RF and Belardinelli L (1993) Selective potentiation by an A1 adenosine receptor enhancer of the negative dromotropic action of adenosine in the guinea pig heart. J Pharmacol Exp Ther 266:611-617.
2. Belardinelli L, Linden J and Berne RM (1989) The cardiac effects of adenosine. Prog Cardiovasc Dis 32:73-97.
3. 1 adenosine receptor coupling to G proteins. Biochim Biophys Acta 1265: 15-21.
4. Birnbaumer L, Abramowitz J and Brown AM (1990) Receptor-effector coupling by G proteins. Biochim Biophys Acta 1031:163-224.
5. 1 receptor binding and function by 2-amino-3-benzoylthiophenes. Mol Pharmacol 38:939-949.
6. 1 receptor binding by 2-amino-3-benzoylthiophenes. Mol Pharmacol 38:950-958.
7. Bushfield M and Johnson RA (1990) Regulation of adenylate cyclase by adenosine: Characterization of the P-site. Biochem Soc Trans 18:150-151.
8. Clemo HF and Belardinelli L (1986) Effect of adenosine on atrioventricular conduction. 1. Site and characterization of adenosine action in the guinea pig atrioventricular node. Circ Res 59:427-436.
9. Daniela CK, Zhang L, Musser B and Vestal RE (1994) A solid-phase radioimmunoassay for cyclic AMP. J Pharmacol Toxicol Methods 31:41-46.
10. Dobson JG (1983) Adenosine reduces catecholamine contractile responses in oxygenated and hypoxic atria. Am J Physiol 245:H468-H474.
11. Dobson JG and Schrader J (1984) Role of extracellular and intracellular adenosine in the attenuation of catecholamine evoked responses in guinea pig heart. J Mol Cell Cordiol 16:813-822.
12. Fleming JW, Wisler PL and Watanabe AM (1992) Signal transduction by G-proteins in cardiac tissues. Circulation 84:420-433.
13. Fredholm B and Sollevi A (1986) Cardiovascular effects of adenosine. Clin Physiol (Oxf) 8:1-21.
14. Hepler J R and Gilman AG (1992) G proteins. Trends Biochem Sci 17:383-387.
15. Ho R and Shi Q (1984) Evidence for a single forskolin-binding site in rat adipocyte membrane. J Biol Chem 259:7630-7636.
16. Hsia JA, Moss J, Hewlett EL and Vaughan M (1984) ADP-ribosylation of adenylate cyclase by pertussis toxin: Effects of inhibitory agonist binding. J Biol Chem 259:1086-1090.
17. a subunit and autonomous regulation of adenylate cyclase. Nature 323:182-184.
18. Janusz CA, Bruns RF and Berman RF (1991) Functional activity of the adenosine binding enhancer, PD 81,723, in the in vitro hippocampal slice. Brain Res 567: 181-187.
19. Kollias-Baker C, Ruble J, Dennis D, Bruns RF, Linden J and Belardinelli L (1994) Allosteric enhancer PD 81,723 acts by novel mechanism to potentiate cardiac actions of adenosine. Circ Res 75:961-971.
20. 1 receptor. J Pharmacol Exp Ther 281:761-768.
21. 125I]Aminobenzyladenosine, a new radioligand with improved specific binding to adenosine receptors in heart. Circ Res 56:279-284.
22. 1 receptor. Am J Physiol 264:H1017-H1022.
23. Musser B, Morgan ME, Leid M, Murray TF, Linden J and Vestal RE (1993) Species comparison of adenosine and β-adrenoceptors in mammalian atrial and ventricular myocardium. Eur J Pharmacol (Mol Pharmacol) 246:105-111.
24. Romano FD and Dobson JG (1996) Adenosine attenuation of isoproterenol-stimulated adenylyl cyclase activity is enhanced with aging in the adult heart. Life Sic 58:493-502.
25. Ruiz JA and Ho RJ (1986) Preparation of rat liver plasma membrane with respect to glucagon-sensitive adenylate cyclase. Anal Biochem 157:47-52.
26. Vitti P, Rotella CM, Valente WA, Cohen J, Aloj SM, Laccetti P, Ambesi-Impiombato FS, Grollman EF, Pinchera A, Toccafondi R and Kohn LD (1983) Characterization of the optimal stimulatory effects of Graves' monoclonal and serum immunoglobulin G on adenosine 3́,5́ monophosphate production in FRTL-5 thyroid cells: A potential clinical assay. J Clin Endrocrinol Metab 57:782-791.
27. Warner EL, Galasso F, Thompson CI and Belloni FL (1992) Vasodilative and antiadrenergic effects of adenosine in diabetic rat hearts. Can J Physiol Pharmacol 70:13-19.